1. Home
  2. Analysis
  3. Minoxidil
  4. Korlym

Minoxidil and Korlym drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 7 people who take Minoxidil and Korlym. Common interactions include constipation among females, and balance disorder among males.

The phase IV clinical study analyzes what interactions people who take Minoxidil and Korlym have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 24, 2023

7 people who take Minoxidil and Korlym together, and have interactions are studied.

What is Minoxidil?

Minoxidil has active ingredients of minoxidil. It is used in hair loss. Currently, eHealthMe is studying from 26,687 Minoxidil users.

What is Korlym?

Korlym has active ingredients of mifepristone. Currently, eHealthMe is studying from 2,981 Korlym users.

Number of Minoxidil and Korlym reports submitted per year:

Minoxidil and Korlym drug interactions.

Common Minoxidil and Korlym drug interactions by gender *:

female:

  1. Constipation
  2. Feeling jittery
  3. Glomerular filtration rate decreased
  4. Peripheral swelling
  5. Weight increased
  6. White blood cell count increased
  7. Adrenal insufficiency
  8. Asthenia
  9. Atrial fibrillation
  10. Bladder cancer

male:

  1. Balance disorder
  2. Dizziness
  3. Fatigue
  4. Death
  5. Myocardial infarction

Common Minoxidil and Korlym drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Death
  2. Myocardial infarction

40-49:

n/a

50-59:

  1. Atrial fibrillation
  2. Confusional state
  3. Dyspnoea
  4. Fall
  5. Hypokalaemia
  6. Hypotension
  7. Hypoxia
  8. Lymphoedema
  9. Nausea
  10. Oedema peripheral

60+:

  1. Balance disorder
  2. Dizziness
  3. Nausea
  4. Peripheral swelling
  5. Weight increased
  6. White blood cell count increased
  7. Fatigue
  8. Arthralgia
  9. Blood creatine increased
  10. Chest pain

* Approximation only. Some reports may have incomplete information.

Do you take Minoxidil and Korlym?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Minoxidil side effects:

Browse all side effects of Minoxidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Korlym side effects:

Browse all side effects of Korlym:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Minoxidil interactions:

Browse all interactions between Minoxidil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Korlym interactions:

Browse all interactions between Korlym and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on minoxidil and mifepristone (the active ingredients of Minoxidil and Korlym, respectively), and Minoxidil and Korlym (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Minoxidil and Korlym.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.